Bisphosphonates: therapeutics potential and recent advances in drug delivery

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Drug Delivery

• Publication date

  2015-01-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/10717544.2013.870259PMID 24404750
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biomedical applications of bisphosphonates.

  2013cited by this paper
• Liposome encapsulation of zoledronic acid results in major changes in tissue distribution and increase in toxicity.

  2013cited by this paper
• Micro-structured hydroxyapatite microspheres for local delivery of alendronate and BMP-2 carriers

  2013cited by this paper
• Improvement in bone properties by using risedronate adsorbed hydroxyapatite novel nanoparticle based formulation in a rat model of osteoporosis.

  2013cited by this paper
• The bisphosphonates: risks and benefits of long term use.

  2013cited by this paper
• Enteric-coated alendronate sodium nanoliposomes: a novel formula to overcome barriers for the treatment of osteoporosis

  2013cited by this paper
• Cast adhesive polyelectrolyte complex particle films of unmodified or maltose-modified poly(ethyleneimine) and cellulose sulphate: fabrication, film stability and retarded release of zoledronate

  2013influential reference
• Raloxifene and alendronate containing thin mesoporous titanium oxide films improve implant fixation to bone.

  2013cited by this paper
• Suitability of liposomal carriers for systemic delivery of risedronate using the pulmonary route

  2013cited by this paper
• Silicon-stabilized α-tricalcium phosphate and its use in a calcium phosphate cement: characterization and cell response.

  2012cited by this paper
• Prevention and treatment of osteoporosis in women: an

  2012cited by this paper
• Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system.

  2012cited by this paper
• Bone metastasis targeting: a novel approach to reach bone using Zoledronate anchored PLGA nanoparticle as carrier system loaded with Docetaxel.

  2012cited by this paper
• Bone targeting for the treatment of osteoporosis.

  2012cited by this paper
• Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer.

  2012cited by this paper
• Topically administered Risedronate shows powerful anti-osteoporosis effect in ovariectomized mouse model.

  2012cited by this paper
• Self-assembly nanoparticles for the delivery of bisphosphonates into tumors.

  2011cited by this paper
• The balance between adipogenesis and osteogenesis in bone regeneration by platelet-rich plasma for age-related osteoporosis.

  2011cited by this paper
• Combined effects of zoledronate and mechanical stimulation on bone adaptation in an axially loaded mouse tibia.

  2011influential reference
• Ion pairs of risedronate for transdermal delivery and enhanced permeation rate on hairless mouse skin.

  2011cited by this paper
• Nanotechnologies to use bisphosphonates as potent anticancer agents: the effects of zoledronic acid encapsulated into liposomes.

  2011cited by this paper
• Investigation of alendronate-doped apatitic cements as a potential technology for the prevention of osteoporotic hip fractures: critical influence of the drug introduction mode on the in vitro cement properties.

  2011cited by this paper
• Epidemiology of hip fracture: Worldwide geographic variation

  2011influential reference
• In vivo bone augmentation in an osteoporotic environment using bisphosphonate-loaded calcium deficient apatite.

  2010cited by this paper
• In situ fabrication of alendronate-loaded calcium phosphate microspheres: controlled release for inhibition of osteoclastogenesis.

  2010cited by this paper
• Evaluation of a novel osteoporotic drug delivery system in vitro: alendronate-loaded calcium phosphate cement.

  2010cited by this paper
• Superparamagnetic Bifunctional Bisphosphonates Nanoparticles: A Potential MRI Contrast Agent for Osteoporosis Therapy and Diagnostic

  2010cited by this paper
• Development of a novel transdermal patch of alendronate, a nitrogen‐containing bisphosphonate, for the treatment of osteoporosis

  2010cited by this paper
• Targeted Liposomal Drug Delivery to Monocytes and Macrophages

  2010cited by this paper
• A novel PHBV/HA microsphere releasing system loaded with alendronate

  2009cited by this paper
• Prevention and treatment of osteoporosis in women: an update

  2009influential reference
• Locally delivered bisphosphonate for enhancement of bone formation and implant fixation.

  2009cited by this paper
• Synthesis of calcium phosphate-binding liposome for drug delivery.

  2009cited by this paper
• Alendronate and Pamidronate calcium phosphate bone cements: setting properties and in vitro response of osteoblast and osteoclast cells.

  2009cited by this paper
• Enhancing Alendronate Release from a Novel PLGA/Hydroxyapatite Microspheric System for Bone Repairing Applications

  2009cited by this paper
• A novel biomaterial for osteotropic drug nanocarriers: synthesis and biocompatibility evaluation of a PLGA-ALE conjugate.

  2009cited by this paper
• Nanoparticle-based targeted drug delivery.

  2009cited by this paper
• Effect of combined local treatment with zoledronic acid and basic fibroblast growth factor on implant fixation in ovariectomized rats.

  2009cited by this paper
• Biocompatibility of poly(D,L-lactide-co-glycolide) nanoparticles conjugated with alendronate.

  2008cited by this paper
• Bisphosphonates: mechanism of action and role in clinical practice.

  2008cited by this paper
• Preparation of Alendronate Liposomes for Enhanced Stability and Bioactivity: In Vitro and In Vivo Characterization

  2008cited by this paper
• Calcium phosphate bone cements

  2008cited by this paper
• Bone targeting potential of bisphosphonate-targeted liposomes. Preparation, characterization and hydroxyapatite binding in vitro.

  2007cited by this paper
• Design of surface-modified poly(D,L-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone.

  2007cited by this paper
• Local delivery of bisphosphonate from coated orthopedic implants increases implants mechanical stability in osteoporotic rats.

  2006cited by this paper
• Management of the adverse effects associated with intravenous bisphosphonates.

  2006cited by this paper
• Bisphosphonates

  2006cited by this paper
• The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs

  2006cited by this paper
• Molecular Mechanisms of Action of Bisphosphonates: Current Status

  2006cited by this paper
• Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws.

  2006cited by this paper
• Comparing ectopic bone growth induced by rhBMP‐2 on an absorbable collagen sponge in rat and rabbit models

  2006cited by this paper
• Systematic Review: Bisphosphonates and Osteonecrosis of the Jaws

  2006cited by this paper
• Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies.

  2005cited by this paper
• Bone-targeting macromolecular therapeutics.

  2005cited by this paper
• THE OTTO AUFRANC AWARD: Bone Augmentation around and within Porous Implants by Local Bisphosphonate Elution

  2005cited by this paper
• Bisphosphonate mechanism of action.

  2003cited by this paper
• Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation.

  2003cited by this paper
• New approaches to pharmacological treatment of osteoporosis.

  2003cited by this paper
• Bisphosphonate mechanism of action

  2002cited by this paper
• Osteoporosis prevention, diagnosis, and therapy.

  2001cited by this paper
• Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption.

  2000cited by this paper
• ESOPHAGITIS ASSOCIATED WITH THE USE OF ALENDRONATE

  2000cited by this paper
• The diagnosis and treatment of osteoporosis: future prospects.

  1999cited by this paper
• Stimulatory effect of growth hormone on bone resorption and osteoclast differentiation.

  1996cited by this paper
• Esophagitis associated with the use of alendronate.

  1996cited by this paper
• Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.

  1996cited by this paper
• Osteotropic drug delivery system (ODDS) based on bisphosphonic prodrug. III: Pharmacokinetics and targeting characteristics of osteotropic carboxyfluorescein.

  1996cited by this paper
• Studies of the oral bioavailability of alendronate

  1995cited by this paper
• The relationship between bone density, mineral content, and mechanical strength in the femoral neck.

  1982cited by this paper

• A biointerface-engineered gold nanocluster platform for icariin delivery: Dual-pathway modulation of osteoblast and osteoclast dynamics in osteoporosis therapy.

  2026cites this paper
• Effectiveness and safety of antiresorptive drugs in patients with systemic sclerosis—a retrospective monocentric study

  2025cites this paper
• Transferrin-modified Gemcitabine Encapsulated Polymeric Nanoparticles Persuaded Apoptosis in U87MG Cells and Improved Drug Availability in Rat Brain: An Active Targeting Strategy for Treatment of Glioma.

  2025cites this paper
• [Osteoporosis treatment in systemic sclerosis : Challenges and strategies in daily clinical practice].

  2025cites this paper
• In vitro Bone Tissue Engineering Strategies: The Relevance of Cells and Culturing Methods in Bone Formation and Remodeling.

  2025cites this paper
• From Sophora japonica to Smart Nanomedicine: Molecular Docking Simulations and Multifaceted Applications of CaO Nanoparticles

  2025cites this paper
• Transdermal delivery of risedronate via spanlastics for osteoporosis: formulation optimization, skin deposition, and pharmacokinetic assessment.

  2025cites this paper
• Formulation and assessment of penetration potential of Risedronate chitosan nanoparticles loaded transdermal gel in the management of osteoporosis: In vitro and ex vivo screening

  2024cites this paper
• The Role of the Receptor Activator of Nuclear Factor Kappa-B Ligand/Osteoprotegerin Ratio in Vascular Diseases: A Therapeutic Approach

  2024cites this paper
• Photocrosslinked gelatin/chondroitin sulfate/chitosan-based composites with tunable multifunctionality for bone tissue regeneration.

  2024cites this paper
• Novel Approaches for the Enhancement of Bioavailability of Drugs: An Updated Review.

  2024cites this paper
• Materials-based nanotherapeutics for injured and diseased bone

  2023cites this paper
• Structural Diversity in Antiosteolytic Bisphosphonates: Deciphering Structure-Activity Trends in Ultra Long Controlled Release Phenomena.

  2023cites this paper
• Impact of beta-tricalcium phosphate on preventing tooth extraction-triggered bisphosphonate-related osteonecrosis of the jaw in rats

  2023cites this paper
• Comparative evaluation of the clinical and radiographic efficacy of 0.05% Zoledronate gel as local drug delivery system in treating intrabony defects in stage III grade B periodontitis patients with and without type-2 diabetes mellitus - A randomized split-mouth clinical trial.

  2023cites this paper
• Brief review: Applications of nanocomposite in electrochemical sensor and drugs delivery

  2023cites this paper
• Nitrogen-Containing Bisphosphonates Downregulate Cathepsin K and Upregulate Annexin V in Osteoclasts Cultured In Vitro

  2023cites this paper
• Bench-to-bedside: Feasibility of nano-engineered and drug-delivery biomaterials for bone-anchored implants and periodontal applications

  2022cites this paper
• How Efficient are Alendronate-Nano/Biomaterial Combinations for Anti-Osteoporosis Therapy? An Evidence-Based Review of the Literature

  2022cites this paper
• Transdermal formulations and strategies for the treatment of osteoporosis

  2022cites this paper
• Dietary Effects of Nanopowder Eggshells on Mineral Contents, Bone Turnover Biomarkers, and Regulators of Bone Resorption in Healthy Rats and Ovariectomy-Induced Osteoporosis Rat Model

  2022cites this paper
• Nanofibrous polycaprolactone-polyethylene glycol-based scaffolds embedded with pamidronate: fabrication and characterization

  2022cites this paper
• Sustained delivery of growth factors and alendronate using partially demineralized dentin matrix for endogenous periodontal regeneration

  2021cites this paper
• Synthesis of Aminomethylene-gem-bisphosphonates Containing an Aziridine Motif: Studies of the Reaction Scope and Insight into the Mechanism.

  2021cites this paper
• Recent Advances in Nanomedicine for the Diagnosis and Treatment of Prostate Cancer Bone Metastasis

  2021cites this paper
• Zoledronic acid-loaded lipidic nanoparticles enhance apoptosis and attenuate invasiveness by inhibiting epithelial to mesenchymal transition (EMT) in HepG2 cancer cells

  2021cites this paper
• Bone-Targeting Polymer Vesicles for Effective Therapy of Osteoporosis.

  2021cites this paper
• Spatiotemporally controlled calcitonin delivery: Long-term and targeted therapy of skeletal diseases.

  2021cites this paper
• A review on re-packaging of Bisphosphonates using biomaterials.

  2021cites this paper
• Bisphosphonate-Based Conjugates and Derivatives as Potential Therapeutic Agents in Osteoporosis, Bone Cancer and Metastatic Bone Cancer

  2021cites this paper
• Antiviral Actions of 25-Hydroxycholesterol in Fish Vary With the Virus-Host Combination

  2021cites this paper
• nCP:Fe Nanocontrast Agent for Magnetic Resonance Imaging-Based Early Detection of Liver Cirrhosis and Hepatocellular Carcinoma.

  2021cites this paper
• Synthesis and drug delivery properties of Ibuprofen-Cellulose nanofibril system.

  2021cites this paper
• Functionalization of octacalcium phosphate for bone replacement

  2020cites this paper
• Temperature-responsive hydroxypropyl methylcellulose-N-isopropylacrylamide aerogels for drug delivery systems

  2020cites this paper
• Antibiotic-loaded chitosan-gelatin scaffolds for infected seawater immersion wound healing.

  2020cites this paper
• Zeolitic Imidazolate Framework-8 Encapsulating Risedronate Synergistically Enhances Osteogenic and Antiresorptive Properties for Bone Regeneration.

  2020cites this paper
• Drugs for Treatment of Osteoporosis

  2019cites this paper
• Multifunctionalization Modulates Hydroxyapatite Surface Interaction with Bisphosphonate: Antiosteoporotic and Antioxidative Stress Materials.

  2019cites this paper
• Efficacy of Concanavalin-A conjugated nanotransfersomal gel of apigenin for enhanced targeted delivery of UV induced skin malignant melanoma

  2019cites this paper
• Cardiovascular Outcomes of Romosozumab and Protective Role of Alendronate.

  2019cites this paper
• Co-administration of Systemic and Intralesional Zoledronic Acid in a Case of Fibrous Dysplasia: A Potentially Novel Therapy

  2019cites this paper
• Modulation of Alendronate release from a calcium phosphate bone cement: An in vitro osteoblast‐osteoclast co‐culture study

  2019cites this paper
• Nanocellulose/Gelatin Composite Cryogels for Controlled Drug Release

  2019cites this paper
• Alendronate-Anionic Clay Nanohybrid for Enhanced Osteogenic Proliferation and Differentiation

  2019cites this paper
• Bisphosphonates Zometa and Fosamax Synergize with Metformin to Prevent AOM-Induced Colon Cancer in F344 Rat Model

  2019cites this paper
• Pre-treatment with Pamidronate Improves Bone Mechanical Properties in Mdx Mice Treated with Glucocorticoids

  2018cites this paper
• Paradoxical side effects of bisphosphonates on the skeleton: What do we know and what can we do?

  2018cites this paper
• Calcium Phosphates as Delivery Systems for Bisphosphonates

  2018cites this paper
• Formulation optimization and pharmacokinetics evaluation of oral self-microemulsifying drug delivery system for poorly water soluble drug cinacalcet and no food effect

  2018cites this paper
• Preparation and Optimization of Rivaroxaban by Self-Nanoemulsifying Drug Delivery System (SNEDDS) for Enhanced Oral Bioavailability and No Food Effect

  2018cites this paper
• The underlying pathophysiology and therapeutic approaches for osteoporosis

  2018cites this paper
• Bone-targeted methotrexate–alendronate conjugate inhibits osteoclastogenesis in vitro and prevents bone loss and inflammation of collagen-induced arthritis in vivo

  2018cites this paper
• Spray‐congealed solid lipid microparticles as a new tool for the controlled release of bisphosphonates from a calcium phosphate bone cement

  2018cites this paper
• Positive effect of alendronate on bone turnover in ovariectomised rats’ osteoporosis: comparison of transdermal lipid-based delivery with conventional oral administration

  2018cites this paper
• Osteoporosis: A Clinical Update for Home Healthcare Clinicians

  2018cites this paper
• Targeted Nanomedicine to Treat Bone Metastasis

  2018cites this paper
• Identification and imaging of miR-155 in the early screening of lung cancer by targeted delivery of octreotide-conjugated chitosan-molecular beacon nanoparticles

  2018cites this paper
• Carbon nanospheres conjugated bisphosphonates: synthesis, characterization and in vitro antimalarial activity

  2018cites this paper
• Bioceramics as drug delivery systems

  2018cites this paper
• An effective method for bisphosphonate moiety inserting into O–H bond of carboxylic acids by Cu (II) catalyst

  2018cites this paper
• Aminobisphosphonates based on cyclohexane backbone as coordinating agents for metal ions. Thermodynamic, spectroscopic and biological studies

  2018cites this paper
• Prophylactic Bisphosphonate Therapy to Reduce Glucocorticoid-Induced Osteoporosis in a Mouse Model of Duchenne Muscular Dystrophy

  2018cites this paper
• Osteoporosis

  2018cites this paper
• Efficacy of Denosumab for Osteoporosis in Three Female Patients with Osteogenesis Imperfecta.

  2017influential citation
• Nanoparticles: a promising new therapeutic platform for bone regeneration?

  2017cites this paper
• Gelatin Porous Scaffolds as Delivery Systems of Calcium Alendronate.

  2017cites this paper
• Role of Nanoparticles in Drug Delivery and Regenerative Therapy for Bone Diseases.

  2017cites this paper
• Ceramide lipid-based nanosuspension for enhanced delivery of docetaxel with synergistic antitumor efficiency

  2017cites this paper
• The role of monocyte subpopulations in vascular injury following partial and transient depletion

  2017cites this paper
• Hyperprolactinemia Induced by Antipsychotics: From Diagnosis to Treatment Approach.

  2017cites this paper
• Functionalized Biomimetic Calcium Phosphates for Bone Tissue Repair

  2017influential citation
• Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals

  2017cites this paper
• Hydroxyapatite functionalization to trigger adsorption and release of risedronate.

  2017cites this paper
• Risedronate transdermal delivery system based on a fumaric copolymer for therapy of osteoporosis.

  2017cites this paper
• Fluorous-tag assisted synthesis of bile acid-bisphosphonate conjugates via orthogonal click reactions: an access to potential anti-resorption bone drugs.

  2017cites this paper
• Design of calcium phosphate ceramics for drug delivery applications in bone diseases: A review of the parameters affecting the loading and release of the therapeutic substance.

  2017cites this paper
• Inhalable clarithromycin liposomal dry powders using ultrasonic spray freeze drying

  2017cites this paper
• Hydrophosphonylation of Alkynes with Trialkyl Phosphites Catalyzed by Nickel

  2017cites this paper
• Application of self-emulsifying delivery systems for effective delivery of nutraceuticals

  2016cites this paper
• Multifunctional nanocarriers for codelivery of nucleic acids and chemotherapeutics to cancer cells

  2016cites this paper
• Some recent advances on liposomal and niosomal vesicular carriers

  2016cites this paper
• Relaxations of fluorouracil tautomers by decorations of fullerene-like SiCs: DFT studies

  2016cites this paper
• Nanoemulsion as a topical delivery system of antipsoriatic drugs

  2016cites this paper
• Pathophysiology of Metastatic Bone Disease and the Role of the Second Generation of Bisphosphonates: From Basic Science to Medicine.

  2016cites this paper
• Pharmacokinetic and therapeutic efficacy of intrapulmonary administration of zoledronate for the prevention of bone destruction in rheumatoid arthritis

  2016cites this paper
• Alendronate Functionalized Mesoporous Bioactive Glass Nanospheres

  2016cites this paper
• Pickering emulsions: challenges and opportunities in topical delivery

  2016cites this paper
• Ultradeformable Liposomes: a Novel Vesicular Carrier For Enhanced Transdermal Delivery of Procyanidins: Effect of Surfactants on the Formation, Stability, and Transdermal Delivery

  2016cites this paper
• The blood-tendon barrier: identification and characterisation of a novel tissue barrier in tendon blood vessels.

  2016cites this paper
• A photo-responsive peptide- and asparagine–glycine–arginine (NGR) peptide-mediated liposomal delivery system

  2016cites this paper
• Effect of backing films on the transdermal delivery of cyclobenzaprine patch

  2016cites this paper
• Pharmacokinetics and tolerability of minodronic acid tablets in healthy Chinese subjects and food and age effects on the pharmacokinetics.

  2015cites this paper
• Ex vivo alendronate localization at the mesoporous titania implant/bone interface

  2015cites this paper
• In vitro and in vivo study of Baicalin-loaded mixed micelles for oral delivery

  2015cites this paper
• Effects of Microbubble Size on Ultrasound-Induced Transdermal Delivery of High-Molecular-Weight Drugs

  2015cites this paper
• Antiresorption implant coatings based on calcium alendronate and octacalcium phosphate deposited by matrix assisted pulsed laser evaporation.

  2015cites this paper
• Actively targeted delivery of doxorubicin to bone metastases by a pH-sensitive conjugation.

  2015cites this paper
• Efficacy and Safety of Denosumab in Postmenopausal Women With Osteoporosis

  2015influential citation
• Salvia miltiorrhiza: an ancient Chinese herbal medicine as a source for anti-osteoporotic drugs.

  2014cites this paper